Table 2 Clinical characteristics of the study participants

Age (years)

49.1 ± 12.9 (26–78)

55.8 ± 18.6 (24–83)

Weight (kg)

78.6 ± 16 (47.7–112.5)

80.8 ± 18.9 (55–126)

Height (cm)

169.7 ± 8.8 (152.4–195.6)

168.3 ± 9.5 (149.9–188)

BMI (kg/m²)

27.3 ± 5 (17.5–37)

28.5 ± 6.1 (18.4–44.4)

Blood glucose (mg/dl)

92.1 ± 13.4 (62–130)

97.4 ± 23.1 (66–156)

Fasting period (h)

10.6 ± 2.8 (6–16)

11.2 ± 3.8 (6–18)

Liver-Spleen (HU)

10.1 ± 7.7 (-5.1–21.1)

6.9 ± 10.9 (-31.1–17.7)

Sex

F

28

14

M

20

11

Race^a

White

24

17

Black or African American

6

1

Asian

5

1

American Indian or Alaska Native

2

0

More than one race

0

1

Other

0

4

Ethnicity^a

Hispanic

7

5

Not Hispanic or Latino

30

20

Hypercholesterolemia^a

Negative

20

22

Positive (not on statin)

6

1

Positive (on statin)

4

1